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Four bisbenzylisoquinoline alkaloids, antioquine, berbamine, gyrocarpine and isotetrandrine were tested in 
BALB/c mice infected with Leishmania amazonensis (IFLA/BR/67/PH8 or MHOM/GF/S4/CAY-H-142) or L. 
uenezuelensis (VE/74/PM-H3). The treatments were initiated 1 day after the parasitic infection, with alkaloid at 
100 mg/kg/day for 14 days and the reference compound, meglumine antimonate (GlucantimeR) at 200 mg/kg/day. 
Antioquine, berbamine and gyrocarpine were less potent than Glucantime against L. amazonensis (PH8). Only 
isotetrandrine exhibited activity approximately equal to or greater than Glucantime in BALB/c mice infected 
with L. amazonensis (PH8 or H-142) and showed significant activity against L. uenezuelensis. Experiments with a 
single local treatment on the footpad, 2 weeks after parasitic infection with L. amazonensis (PHS), showed that 
isotetrandrine at 200 mglkg was less active than Glucantime at 400 mg/kg. 
Keywords: bisbenzylisoquinoline alkaloids; antioquine; berbamine; gyrocarpine; isotetrandrine; BALB/c 
mice; Leishmania amazonensis; L. venezuelensis. 
INTRODUCTION 
The cutaneous and mucosal forms of leishmaniasis due 
to Leishmania braziliensis species constitute an import- 
ant public health problem in South America, particu- 
larly in the areas of colonization of the humid lowlands 
in Bolivia. Although significant advances in the chemo- 
therapy of leishmaniasis have been identified with new 
potential drugs, liposomal amphotericin B (Croft et al., 
1991) and interferon-y in liposomes (Hockertz et al., 
1991), the classic treatments used to cure leishmaniasis 
remain the pentavalent antimonials, PentostamR and 
GlucantimeR. Generally, antimony treatment failures 
are cured with further courses of antimony, with 
amphotericin B or with pentamidine (Saenz and Paz, 
In Bolivia, we established a programme to identify 
new effective drugs, principally natural compounds, for 
the treatment of cutaneous leishmaniasis. In previous 
studies, we reported the in vitro antileishmanial and 
trypanocidal activities of bisbenzylisoquinoline alka- 
loids (Fournet . et al., 1988a, 1988b). 
Bi~benzylisoquinoline alkaloids constitute a series of 
almost 400 phenylalanine-derived metabolites with a 
rich and varied chemistry and pharmacology (Schift, 
1991). For this study, we chose four bisbenzylisoquino- 
lines which displayed in vitro activity at 10pglmL 
against promastigote forms of three strains of 
Leishmania ssp.: L. braziliensis, L. amazonensis and 
L. donovani. The aims of this study were to evaluate 
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the activity of these bisbenzylisoquinoline alkaloids in 
BALB/c mice infected with parasites of the Leishmania 
mexicana complex; Leishmania amazonensis and L. 
venezuelensis. 
MATERIALS AND METHODS 
Animals. Female or male BALBlc mice were supplied 
by Charles River Breeding Laboratory and then were 
bred in IBBA (Bolivia). Mice weighed 18-20g and 
were 8 weeks old when bioassays were initiated. 
Leishmania strains. Leishmania amazonensis 
IFLA/BR/67/PH8 and MHOM/GF/84/CAY-H-142 and 
L. venezuelensis VE/74/PM-H3 were used. The source 
and history of this isolate have been described by 
Bonfante-Garrido (1983). It is an effective parasite 
strain producing severe single and multiple cutaneous 
lesions in human infection (Hanham et al., 1990), and 
in BALB/c mice and hamsters a rapid growth of lesions 
in the footpad. The mouse footpad infection has been 
used as model for these experiments (Avila et al., 1990; 
Coleman et al., 1989). BALBlc mice (n  = 10, n = 8 or 
n = 6) were infected subcutaneously in the right rear 
footpad with 1 x lo6 amastigotes obtained from donor 
hamsters. The parasites were inoculated in 200 pL 
phosphate buffered saline (PBS). 
The growth of the lesion was determined weekly by 
measuring the diameter of both rear feet with a direct 
reading vernier caliper (Kroelin 10DI 00T6). The size 
o f t  e esion in millimetres (index of leishmaniasis) was 
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Figure 1. Structures of antioquine (I) ,  berbamine (II), gyrocar- 
pine (111) and isotetradrine (IV). 
calculated by subtracting the measurements obtained 
for the uninfected foot from that of the infected foot., 
.Measurements were commenced 1 day before the 
inoculation of amastigotes and continued for S or 9 
weeks. For each experiment, the mean and standard 
error of the mean (SEM) were calculated. 
Drug treatment. Glucantime (meglumine antimonate) 
from Rhône-Poulenc, France was used as the reference 
drug. The structures of bisbenzylquinoline alkaloids 
used in this study are shown in Fig. 1. Antioquine was 
isolated from Pseudoxandra sclerocarpa (Annonaceae) 
(Cortes et al., 1985), berbamine from Berberis boli- 
viana (Berberidaceae) (Weber er al., 1989), gyrocar- 
pine from Gyrocarpus americanas (Hernandiaceae) 
(Chalandre er al., 1986) and isotetrandrine from 
Limaciopsis loangensis (Menispermaceae) (Fournet, 
1979). 
Two experiments were conducted. Mice in the first 
experiment were treated by the subcutaneous route. 
Glucantime was given at a dose of 200 mg/kg/day and 
bisbenzylisoquinoline alkaloids (antioquine, berba- 
mine , gyrocarpine and isotetrandrine) at 100 mg/kg/ 
day. The bisbenzylisoquinoline alkaloids were dis- 
solved in 40 pL of polysorbate (Tween 80, Prolabo), 
Glucantime in PBS. The untreated mice received PBS 
and Tween SO. Drug treatment commenced 1 day after 
the inoculation of amastigotes and was continued once 
daily for 14 days. 
In the second experiment, mice were treated directly 
on the infected rear footpad with a single treatment 14 
days after the inoculation of parasites. For this experi- 
ment, the mice were treated with Glucantime at 
400 mg/kg/day and with isotetrandrine at 200 mg/kg/ 
day. 
RESULTS 
Effects of bisbenzyIisoquínoline alkdoids on 
Leishmania amazonensis PH8 
The activities of antioquine, berbamine and gyrocar- 
pine against cutaneous leishmaniasis caused by 
Leishmania amazonensis (PH8) in BALB/c mice are 
presented in Table 1. Six weeks after infection, mice 
treated with antioquine or with berbamine had an 
average lesion size of 2.25 mm and 2.52 mm respecti- 
vely, compared with 1.69 mm in the mice treated with 
Glucantime and 3.83 mm in the untreated mice..During 
the last 3 weeks'of the experiment, the lesion size 
increased twice as rapidly in mice treated with antio- 
quine (4.05 mm) or with berbamine (2.74 mm) than in 
mice treated with Glucantime (1.97 mm). Gyrocarpine 
was found to be less effective than the standard penta- 
valent antimonial drug and the other bisbenzylisoqui- 
noline alkaloids. The lesion sizes measured in mice 
BALB/c treated with gyrocarpine and untreated mice 
did not differ significantly after 9 weeks (6.38 mm and 
6.91 mm, respectively). 
The effects of isotetrandrine are shown in Fig. 2. The 
Table I. Effect of Glucantime (200 mg/kg/day), antioquine (I) (100 mgkglday), 
,berbamine (II) (100 mglkglday) and gyrocarpine @I) (100 mglkglday) on 
the development of L. amazonensis (PHS) in BALB/c mice (-I-SEM). Drug 
were given for 14 day period commencing 1 day after inoculation of L. 
amazonensis 
Diameter of lesion' 
Weeks post- Antioquine Berbamine Gyrocarpine 
infection Control Glucantime (11 (II) (111) 
2 0.31 (0.15) 0.34 (0.08) 0.20 (0.14) 0.30 (0.12) 0.14 (0.04) 
4 1.64 (0.27) 0.86 (0.23) 0.73 (0.24) 0.77 (0.19) 1.39 (0.32) 
6 3.83 (0.60) 1.69 (0.29) 2.25 (0.66) 2.52 (0.73) 3.28 (0.62) 
8 6.01 (0.88) 3.23 (0.87) 4.82 (0.92) 4.57 (0.74) 5.48 (0.65) 
9 6.91 (0.70) 3.66 (1.03) 6.30 (0.49) 5.26 (1.23) 6.38 (0.67) 
a Average measurement (in mm) for 8 mice and +SEM. 
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Figure 2. Effects of isotetrandrine (IV) (100 mglkglday) and 
Glucantime (200 mg/kg/day) on the development of L. amazo- 
nensis (PH8) in BALB/c mice (n= IO, +SEM)/Treatments were 
given for a 14 day period commencing 1 day after inoculafion of 
L. amazonensis. 
mice treated with isotetrandrine and with Glucantime 
developed similar lesion sizes for 6 weeks, 2.14 mm and 
2.35". In the last 2 weeks of the experiment, an 
inhibition of the increase in lesion size in mice treated 
with isotetrandrine (1.15 mm) in comparison with mice 
treated with Glucantime (1.67 mm) was observed. 
Table 2 presents the results obtained with a local 
treatment near the site of the lesion on the infected 
footpad, 14 days after the parasitic infection with amas- 
tigotes of Leishmania amazoizeizsis (PH8). Eight weeks 
after infection, the lesion sizes were 2.83" and 
3.95 mm, respectively, for isotetrandrine and 
Glucantime and 4.90 mm in the untreated mice. 
Effects of isotetrandrine on Leishmania amazonensis 
M-142 
Only the bisbenzylisoquinoline isotetrandrine was 
tested in BALB/c mice infected with Leishmania ama- 
zonensis H-142. The results of this experiment are 
shown in Table 3. The growth of experimental cuta- 
neous leishmaniasis with strain H-142 was slower than 
with strain PH8. After 9 weeks, mice treated with 
isotetrandrine had an average lesion size of 1.73 mm, 
1.98 mm in mice treated with Glucantime and 2.96 mm 
in the untreated mice. With this strain of cutaneous 
leishmaniasis, after 10 weeks there was a beginning of 
ulceration or healing of the lesions. 
Table 2. Effect of Glucantime (400 mg/kg/day), and isotetran- 
drine (IV) (200 mg/kg/day), on the development of L. 
amazonensis (PHS) in BALB/c mice (+SEM). Drugs 
were given on the infected rear footpad with a single 
treatment 14 days after the inoculation of L. amazo- 
nensis 
Diameter of lesiona 
Weeks post-infection Control Glucantime lsotetrandrine (IV) 
2 0.35 (0.08) 0.45 (0.05) 0.55 (0.15) 
4 1.02 (0.20) 0.53 (0.23) 1.05 (0.33) 
6 2.87 (0.29) 1.52 (0.38) 2.45 (0.75) 
8 4.90 (0.42) 2.83 (0.58) 3.95 (1.12) 
a Average measurement (in mm) for 6 mice and +SEM. 
Table 3. Effect of Glucantime (200 mg/kg/day), and isotetran- 
drine (I) (100 mg/kg/day), on the development of L. 
amazonensis (H-142) in BALB/c mice (&SEM). 
Drugs were given for a 14 day period commencing 1 
day after inoculation of L. amazonensis 
Diameter of lesiona 
Weeks post-infection Control Glucantime lsotetrandrine (IV) 
2 0.53 (0.12) 0.42 (0.10) 0.18 (0.07) 
4 0.88 (0.12) 0.67 (0.18) 0.34 (0.11) 
6 1.43 (0.44) 0.66 (0.24) 0.68 (0.21) 
8 2.02 (0.45) 1.30 (0.30) 1.41 (0.67) 
9 2.96 (0.46) 1.98 (0.34) 1.73 (0.62) 
a Average measurement (in mm) for 10 mice and +SEM. 
Effects of isotetrandrine on Leishmania venezuelensis 
03-31 
The BALB/c mice infected with the effective strain L. 
venezuelensis and treated with 100 mg/kg/day of isote- 
trandrine for 14 days or with pentavalent antimonial 
developed identical lesion sizes (Table 4). An increase 
in lesion size was observed in all mice between week 4 
and the last week of the experiment, 4.53" in 
untreated mice, and in mice treated with Glucantime 
and isotetrandrine 3.30 mm and 3.78 mm. 
~~ ~~ 
DISCUSSION 
This study on the evaluation of the in vivo antileishma- 
nia1 activity of some bisbenzylisoquinoline alkaloids, on 
BALB/c mice infected with New World strains of 
cutaneous leishmaniasis, shows the efficacy of one com- 
pound, isotetrandrine. With the data obtained in our 
models, we observed that isotetrandrine administered 
at 100mglkg in BALB/c mice, is approximately as 
effective as pentavalent antimonials at 56 mg/Sb'/kg 
against two strains of Leishmania amazonensis 
(PH8 and H-142) and slightly less active against L. 
venezuelensis. 
The in vitro activity of isotetrandrine against 
Leishmania ssp. was not described in our previous 
study (Fournet et al., 1988b). Antioquine, berbamine 
and gyrocarpine were not active against L. amazonen- 
sis (PH8) infected BALB/c mice. They had good in 
vitro activity against the promastigote forms of 
Leishmania ssp. We have observed variations in the 
infectivity of parasite strains of Leishmania amazonen- 
sis. With the same inoculum in the footpad, the strain 
Table 4. Effect of Glucantime (200 mg/kg/day) and isotetran- 
drine (100mg/kg/day) on the development of L. 
venezuelensis (H-3) in BALBlc mice (+SEM). Drugs 
were given for 14 day period commencing 1 day after 
inoculation of L. venezuelensis 
Diameter of lesiona 
Weeks post-infection Control Glucantime lsotetrandrine (IV) 
2 0.62 (0.30) 0.45 (0.19) 0.28 (0.08) 
4 2.07 (0.19) 0.95 (0.21) 1.27 (0.12). 
6 4.12 (0.22) 2.48 (0.34) 2.80 (0.52) 
8 6.60 (0.51) 4.25 (0.44) 5.05 (0.66) 
a Average measurement (in mm) for 6 mice and +SEM. 
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PH8 of L. amazonensis and L. uenezuelensis produced 
the fastest growing lesion. For the evaluation of new 
potential drugs active against the New World cutaneous 
leishmaniases, the choice of fast growing strains of 
Leishmania ssp. (PH8) are more sensitive to drugs and 
therefore better indicators of activity compared with 
the slow growing strain (H-142). 
The two bisbenzylisoquinoline alkaloids, berbamine 
(II) and isotetrandrine (IV) have two diphenyl ether 
linkages in positions 8-7' and 11-12' (Fig. 1) with the 
configuration R,S. In position 12, isotetrandrine is 
substituted by a methoxyl-group and berbamine by a 
hydroxyl group. Only isotetrandrine is as effective "as 
meglumine antimonate against Leishmania amazonen- 
sis and L. venezuelensis. The growth of experimental 
leishmaniasis is slower in mice treated with berbamine 
than in untreated mice. This small difference in the 
chemical structure of these two alkaloids shows that it 
will not be easy to find a structure-activity relationship 
with bisbenzylisoquinoline alkaloids. The other com- 
pounds tested present a different chemical structure. 
Gyrocarpine (III) has two diphenyl ether linkages in 
positions 7-8' and 11-12' and antioquine has a diphenyl 
ether linkage in position 8-7' and one diphenyl linkage 
in position 11-1 1'. The antiprotozoal activities of bis- 
benzylisoquinolines have been described by different 
authors against Plastnodiim falcipantm (Partridge et 
al., 1988; Y e  and VanDyke, I989), Plasmodium berg- 
hei berghei (Dreyfuss et al., 1987b) and Trypanosoma 
brucei brucei (Dreyfuss et al., 1987a). 
This is the first reported in viu0 study of the antileish- 
manial activity of bisbenzyloquinoline alkaloids against 
New World cutaneous leishmaniasis, Leishmania ama- 
zonensis and L. uenezuelensis. The study also identified 
a compound, isotetrandrine, with promising antileish- 
manial activity. Further studies will examine activity 
against infection with visceral leishmaniasis (Leishma- 
nia donouani) and continue to investigate the in uivo 
activity against Leishmania ssp. of new bisbenzylisoqui- 
noline alkaloids. 
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